1. Home
  2. POWW vs SABS Comparison

POWW vs SABS Comparison

Compare POWW & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMMO Inc.

POWW

AMMO Inc.

N/A

Current Price

$2.02

Market Cap

225.2M

Sector

Industrials

ML Signal

N/A

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

N/A

Current Price

$3.85

Market Cap

201.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POWW
SABS
Founded
1990
2014
Country
United States
United States
Employees
81
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.2M
201.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POWW
SABS
Price
$2.02
$3.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$2.40
$9.80
AVG Volume (30 Days)
754.3K
691.3K
Earning Date
02-09-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.56
N/A
Revenue Next Year
$0.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$1.00
52 Week High
$2.23
$6.60

Technical Indicators

Market Signals
Indicator
POWW
SABS
Relative Strength Index (RSI) 50.69 46.13
Support Level $1.99 $3.52
Resistance Level $2.20 $4.16
Average True Range (ATR) 0.09 0.30
MACD -0.02 -0.03
Stochastic Oscillator 31.48 12.25

Price Performance

Historical Comparison
POWW
SABS

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: